Abstract: The present invention provide novel emulsion formulations which comprise oil bodies. The invention also provides a method for preparing the emulsions and the use of the emulsions in products for topical application to the skin. The products are very mild to the skin and may be easily formulated into a wide variety of personal care and dermatological products.

Abstract: The present invention relates to oil in water emulsion compositions, their use in medicine, in particular to their use in augmenting immune responses to a wide range of antigens, and to methods of their manufacture; the compositions having oil phase and an aqueous phase, a sterol and a saponin; the sterol being present in the oil phase and the saponin being present in the aqueous phase.

Abstract: An emulsifiable composition for the control of insects, especially of termites, comprising as active ingiedients a 1-substituted phenyl 3-CN pyrazole and a weakly polar solvent and an emulsifying agent, and optionally some further additives or solvents. These compositions avoid the formation of crystals.

Abstract: A product-structuring composition which forms a bilayer lamellar gel network in an oil-in-water system comprising (a) a cationic swellant which is a fatty acid adduct of amidopropyldimethyl-2-hydroxyethyl ammonium halide, and (b) a gellant blend of low HLB emulsifiers having a resultant HLB of about 1.5 to 4.5.

Abstract: Single phase preparations of hydrophilic species, in particular macromolecular compounds such as proteins or glycoproteins in a hydrophobic solvent such as an oil can be obtained by preparing a hydrophile/amphiphile array in which the hydrophilic head groups of the amphiphile are orientated towards the hydrophilic species and bringing the array into contact with the hydrophobic solvent. The preparations of the invention can be used alone or can be combined with an aqueous phase to form emulsions in which the hydrophilic species is present in the hydrophobic phase. The compositions of the present invention are versatile and have application in the pharmaceutical, food, cosmetic, chemical and agricultural industries.

Abstract: A cosmetic composition is provided comprising: A) a cosmetically acceptable carrier; and B) 0.05 to 3.0% by weight, based on the weight of the total composition, of a &bgr;-1,3-scleroglucan having a three-dimensional crosslinked triple helix structure and having a mean molecular weight of 1×106 to 12×106.

Abstract: Organopolysiloxane gels containing gel-bound hydrophillic groups are prepared by reacting a hydrosilylatable unsaturated organopolysiloxane resin, a crosslinker bearing Si—H bound hydrogen, and a hydrosilylatable unsaturated hydrophile, in the presence of an effective amount of a hydrosilylation catalyst, at least a portion of the reaction taking place in the presence of at least 60 weight percent of an oleaginous composition containing at least 50 weight percent low viscosity organopolysiloxane. When sheared, the crosslinked organosiloxane compositions form a stable, preferably incompatible gel which may be used in turn to form a stable emulsion with large amounts of ordinarily incompatible hydrophillic liquids. The emulsions thus formed are suitable for use in a wide variety of cosmetic products.

Abstract: An emulsion comprising an aqueous phase and an oily phase and additionally comprising a hydrophilic thickening compound and a lipophilic thickening copolymer. A cosmetic or dermatological composition comprising, in a cosmetically or dermatologically acceptable medium, such an emulsion. The use of such a combination makes it possible to stabilize an emulsion, in particular an oil-in-water emulsion and more particularly an emulsion not comprising a surfactant.

Abstract: A composition in the form of an anhydrous emulsion having as a dispersed phase ascorbic acid dissolved in a nonaqueous polar organic solvent, and as the continous phase a nonaqueous nonpolar organic solvent, as well as a method for dissolving ascorbic acid.

Abstract: A pharmaceutical composition has a blend of at least first and second components and a medicament in a sufficient amount to be therapeutic where the first component is hydroxypropylcellulose (HPC) and the second component is at least one other polymer selected from the group consisting of methylcellulose (MC), ethylhydroxyethylcellulose (EHEC), hydroxyethylmethylcellulose (HEMC), hydrophobically modified hydroxyethylcellulose (HMHEC), hydrophobically modified ethylhydroxyethylcellulose (HMEHEC), carboxymethylhydroxyethylcellulose (CMHEC), carboxymethyl hydrophobically modified hydroxyethylcellulose (CMHMHEC), guar, pectin, carrageenan, agar, algin, gellan gum, acacia, starch and modified starches, co-polymers of carboxyvinyl monomers, co-polymers of acrylate or methacrylate monomers, mono- and co-polymers of oxyethylene and oxypropylene and mixtures thereof and a medicament in a sufficient amount to be therapeutic, with the proviso that low-substituted hydroxypropylcellulose (L-HPC) is excluded from said firs

Abstract: The invention relates to an active ingredient combination containing erythrulose and a further reducing sugar with self-browning properties, for example dihydroxyacetone, which combination is used for artificially tanning the skin. Compared with compounds containing, for example, only dihydroxyacetone, said active ingredient combination and cosmetic compounds based thereon result in an even and longer-lasting colouring of the skin and prevent skin dehydration and uneven flaking.

Abstract: The present invention relates to the use of at least two compounds chosen from components having an a) anti-radical, b) anti-inflammatory and c) anti-allergic activity for the preparation of a composition exhibiting at least two of the a), b) and c) activities intended for the treatment of sensitive and/or allergic skin. It also relates to a process for the preparation of such compositions and to the compositions thus obtained.

Abstract: The invention is of a topical medicament and associated methodology for use thereof, through the use of which fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations or fibrosis of muscle tissue may be effectively, cost effectively, and painlessly treated. One or more calcium channel blocker agents serve as the primary active ingredient of the present compositions, with carrier agents facilitating non-invasive transdermal delivery of the calcium channel blocker(s) to subdermal disease sites.

Abstract: Pickering emulsions, which are finely disperse systems of the water-in-oil or oil-in-water type, comprising

Abstract: A clear, transparent highly stable skin moisturizing and lubricating composition is provided comprising the product obtained by combining polyglyceryl methacrylate with a pharmaceutically acceptable silicone, in the presence of a suitable emulsifier under application of pressure in the range of about 13,000 to about 50,000 psi. The compositions are adapted for use as cosmetics and/or carriers for active drugs and serve in this form for treatment of skin irritations, burns, skin infections and the like. A method of preparing the compositions of the invention is disclosed. The invention also contemplates methods for lubricating and moisture replenishment of the skin, treating burns, skin infections and the like by topically applying the disclosed skin treatment compositions of the invention.

Abstract: A cosmetic preparation is presented containing (a) alkyl or alkenyl oligoglycosides (b) polyol poly-12-hydroxystearates and (c) dihydroxyacetone. This self-tanning cosmetic preparation has high dermatological compatibility, a favorable feeling on the skin and good storage stability at relatively high temperatures.

Abstract: The disclosure pertains to bio-active preparations, as solutions, emulsions, suspensions suspoemulsions, emulsifiable concentrates, and dispersible granules where the biologically active compound is dissolved in a solvent the general formula RCH(OR′)2, ketals of the formula R2C(OR′)2, or orthoesters of the formula RC(OR′)3, wherein the substituents are defined herein. Acetal from monoaldehyde and alcohol have the general formula (I) Acetals used herein also include structures such as: And more complex acetal compounds as disclosed herein. The biologically active compounds in such preparations are active organic compounds, in particular, herbicides and safeners, insecticides, fungicides, acaricides, nematicides, pheromones and repellents. Embodiments included are oil-in-water (O/W) emulsions, emulsifiable concentrates(EC), water dispersible granules (WG) and suspoemulsion (SE).

Abstract: Methods and apparatus for improving administration of drugs through the use of heat and other physical means. The present invention relates to the use of heat and other physical means in conjunction with specially designed dermal drug delivery systems, conventional commercial dermal drug delivery systems, or drugs delivered into a sub-skin depot site via injection and other methods to alter, mainly increase, the drug release rate from the dermal drug delivery systems or the depot sites to accommodate certain clinical needs.

Abstract: A transfer-resistant make-up or care composition, comprising: a fatty phase, and a volatile solvent comprising a linear decamethyltetrasiloxane and at least one additional solvent which has an evaporation speed that is greater than the evaporation speed of the linear decamethyltetrasiloxane.

Abstract: A method of dispersing an insoluble material in an aqueous solution comprising the following steps: (i) providing a formulation comprising at least one insoluble material and at least one dispersant comprising a water soluble agriculturally acceptable derivative of an alternating copolymer or an agriculturally acceptable salt thereof wherein said alternating copolymer comprises at least one first comonomer residue according to formula I and at least one second comonomer residue according to formula II; and (ii) dispersing said formulation in an aqueous medium. An agricultural formulation comprising at least one insoluble material and at least one dispersant comprising a water soluble agriculturally acceptable derivative of an alternating copolymer or an agriculturally acceptable salt thereof wherein said alternating copolymer comprises at least one first comonomer residue according to formula I and at least one second comonomer residue according to formula II.

Abstract: A composition containing a continuous aqueous phase comprising L-2-oxothiazolidine-4-carboxylic acid, at least one sequestering agent and at least one neutralizing agent, the said neutralizing agent being present in an amount which is sufficient to adjust the pH of the aqueous phase of the composition to a value of between 5 and 8. The combination of the sequestering agent and the neutralizing agent stabilizes the L-2-oxothiazolidine-4-carboxylic acid, in particular with respect to thermal degradation, and thus prevents yellowing of the composition and the formation of unpleasant odors.

Abstract: The invention provides a tea tree oil emulsion comprising tea tree oil at a concentration of greater than about 20% on a weight by weight basis, an emulsifier, and a wherein the emulsion remains stable when packaged in a flexible tube. A method for producing the tea tree oil emulsion and an article of manufacture containing the tea tree oil emulsion is also provided.

Abstract: The invention relates to the use of aminoalcohol derivatives containing a urea functional group corresponding to the following formula: in which: R1 represents a linear or branched, saturated or unsaturated alkyl radical having from 8 to 22 carbon atoms; R2 represents a hydrogen atom or a linear or branched, saturated alkyl radical having from 1 to 6 carbon atoms; R3 represents a linear or branched, monohydroxylated or polyhydroxylated, saturated alkyl group having from 1 to 10 carbon atoms, in and for the preparation of cosmetic or dermatological compositions. These compounds are used in particular as moisturizing agents in care products for the skin or as conditioning agents in hair products.

Abstract: A cosmetic or dermatological composition, comprising: an aqueous phase dispersed in an oily phase with a silicone emulsifying agent, wherein the viscosity of the composition, measured with a Rheomat 180 viscometer at a shear rate of 200 s−1 and at 25° C., ranges from 3 Pa.s (30 poises) to 20 Pa.

Abstract: A medical lubricant suitable for injection into the blood stream of a patient. The lubricant is suitable for use with rotating equipment such as atherectomy drive shafts moving within sheaths and over guide wires and other minimally invasive medical devices introduced into a patient through a catheter like instrument. The lubricant is an oil-in-water emulsion including a surfactant, a co-surfactant, and a pH buffer. The lubricant can further include a cryogenic agent and a pH adjusting agent. One lubricant includes olive oil as an emulsified oil, egg yolk phospholipid as a surfactant, sodium deoxycholate as a co-surfactant, glycerin as a cryogenic agent, L-histidine as a pH buffer, and is pH adjusted using sodium hydroxide. The lubricant can also include a therapeutic agent. The lubricant can withstand freeze/thaw cycles as well as saline dilution, heating, and shear stress without significant creaming, separation, or unacceptable increases in oil droplet size.

Abstract: Polymeric micelles for encapsulation of hydrophobic molecules are provided. Methods and formulations for delivering hydrophobic molecules to a host via these micelles are also provided. Methods of stabilizing liposomes or lipid based formulations by addition of polymeric micelles are also provided.

Abstract: An allantoin-containing skin cream composition can comprise allantoin and at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water. The pH of the composition is in a range of from about 5.0 to about 6.5. The composition can further comprise an acidic anionic polymer. A preferred acidic anionic polymer is a carboxypolymethylene polymer. The composition can further comprise a carbohydrate polymer such as galactoarabinan, polygalactose or polyarabinose. The composition can additionally comprise other ingredients such as herbal extracts, an antioxidant component, an emollient component, a chelator, a solvent component, or a preservative component. The composition is useful as a skin protectant.

Abstract: A fluorohydrocarbon compound of formula RF—C2H4—O—CO—RH, in which RF is a perfluorinated alkyl group and RH is an alkyl group, in and/or for the preparation of a stable emulsion containing at least one fatty phase and one aqueous phase. The invention also relates to the use of the same compound as a stabilizing agent for an emulsion containing at least one fatty phase and one aqueous phase. Another subject of the invention is the use of such a compound as an essential component of the fatty phase of an emulsion and emulsions containing such a fatty phase. Another subject of the invention is a composition comprising such an emulsion.

Abstract: Aqueous bioactive compositions having increased stability and enhanced bioefficacy comprising a bioactive compound, an effective amount of phosphate or phosphonate amphoteric surfactant having multiple ionic charges, and water. The preferred bioactive is a small ionic herbicide such as N-phosphonomethyl glycine or a salt thereof.

Abstract: A composition is intended to form on the skin, by spraying from an erasol can, a film for the transdermal administration of an active agent, and the composition contains 0.01-10% by weight of lipophilic vitamins, hormones, nicotine, corticoids, retinoids, antimycosic agents, anistetics, anolgesics, or anti cancer agents for the skin, 0.5 to 25% by weight of an adhesive polysiloxane composition, 5 to 25% by weight of an absorption promoter, 25 to 95% by weight of a volatile solvent containing at least a volatile silicone, and 0.5 to 50% by weight of pressurized propellant gas, and the composition is substantially free from water.

Abstract: The present invention discloses a method for treating Streptococcal infections of the upper respiratory tract, comprising administering an effective amount of a lysin enzyme produced by group C Streptococcal bacteria infected with a C1 bacteriophage specific for the bacteria to a mouth, throat, or nasal passage of a mammal, the method providing a concentration of from about 100 to 500,000 active enzyme units per milliliter of fluid in the environment of said nasal or oral passages.

Abstract: A fluorohydrocarbon compound of formula RF—C2H4—O—CO—RH, in which RF is a perfluorinated alkyl group and RH is an alkyl group, in and/or for the preparation of a stable emulsion containing at least one fatty phase and one aqueous phase. The invention also relates to the use of the same compound as a stabilizing agent for an emulsion containing at least one fatty phase and one aqueous phase. Another subject of the invention is the use of such a compound as an essential component of the fatty phase of an emulsion and emulsions containing such a fatty phase. Another subject of the invention is a composition comprising such an emulsion.

Abstract: Provided are methods for preparing improved biologically active micelle and crystalline products comprising a biologically active amphipathic compound in association with a micelle or crystalline product. Methods for producing the micelle or crystalline products as well as methods of using the micelle or crystalline products in therapeutic, diagnostic, and cosmetic, applications are also provided.

Abstract: Crushable gel beads 10 formed of an agar complex provide novel cosmetic, pharmaceutical, etc. delivery vehicles for topical delivery of biologically or cosmetically active agents. Preferred agar beads 10 are complexes of a continuous phase of agar gel 12 in a self-supporting solid or semi-solid form with a restraining polymer 14. Entrapped in and dispersed randomly throughout each agar bead 10 is a water-soluble, preferably polar, restraining polymer 14, preferably a quaternized cationic polymer, such as polyquaternium 24 or steardimonium hydroxyethylcellulose. Various active agents 16 may be bound to restraining polymer 14, for example ascorbic acid, lactic acid or papain. Methods of manufacture are also described.

Abstract: The present invention relates to a stabilized self-emulsifying system, comprising a therapeutically effective amount of o-(chloroacetylcarbamoyl)fumigillol, a pharmaceutically acceptable carrier and a stabilizing component, wherein the pharmaceutically acceptable carrier comprises an oily constituent and at least one surfactant. The stabilizing component comprises from about 1% to about 15% water relative to the weight of the self-emulsifying system, an acid, an adsorbent, or a complex-forming agent.

Abstract: The present invention comprises methods and compositions for topically treating and moisturizing keratinous structures of humans and animals including skin, hair, fingernails, toenails, hooves, and horns.

Abstract: A method of preventing damage caused to healthy skin, hair or mucous membranes by free radicals, includes applying to the healthy skin, hair or mucous membrane a composition containing at least one product having a peroxidase activity capable of reducing organic peroxides and at least one antioxidant capable of neutralizing singlet oxygen, the composition being free of peroxide. The product having a peroxidase activity is present in an amount of from 0.005 to 5.0% by weight, and the antioxidant is present in an amount of from 0.005 to 3.0% by weight, with a weight ratio of the product having a peroxidase activity to the antioxidant of from 0.001 to 0.3. The product having a peroxidase activity capable of reducing organic peroxides is lactoperoxidase, and the antioxidant is selected from quinolines, polyphenols, and carotenoids.

Abstract: Block copolymers containing a fluorinated hydrocarbon unit, a hydrocarbon unit, and a poly(oxyethylene) unit are useful in fluid formulations of pharmaceutical agents. A typical embodiment is: C11H23—CONHC2H4NHCO—C8F16—CONHC2H4NHCOO—(C2H4O)34—H.

Abstract: The present invention relates to pharmaceutical compositions, pharmaceutical systems, and methods for enhanced absorption of hydrophilic therapeutic agents. Compositions and systems of the present invention include an absorption enhancing carrier, where the carrier is formed from a combination of at least two surfactants, at least one of which is hydrophilic. A hydrophilic therapeutic agent can be incorporated into the composition, or can be co-administered with the composition as part of a pharmaceutical system. The invention also provides methods of treatment with hydrophilic therapeutic agents using these compositions and systems.

Abstract: The present invention pertains to the use of a cosmetically and dermatologically well-tolerated organic compound containing activated oxygen for preparing a preparation for improving the microcirculation of the skin.

Abstract: Methods and apparatus for improving administration of drugs through the use of heat and other physical means. The present invention relates to the use of heat and other physical means in conjunction with specially designed dermal drug delivery systems, conventional commercial dermal drug delivery systems, or drugs delivered into a sub-skin depot site via injection and other methods to alter, mainly increase, the drug release rate from the dermal drug delivery systems or the depot sites to accommodate certain clinical needs.

Abstract: In order to obtain a makeup cosmetic preparation having natural color-rendering property in response to intensity of surrounding light, a light-responding high color-rendering makeup cosmetic preparation of the present invention is characterized in that titanium oxide or titanium oxide compound, which has photochromic property to darken in response to intensity of irradiated ultraviolet ray, is coated on a surface of mica and metal or metal compound exists on a surface and/or inside of said photochromic titanium oxide coated mica and color of said metal or metal compound is observed as an object color, and wherein an observation color of said photochromic titanium oxide coated mica is changed by emphasizing an interference color generated by darkening of titanium oxide layer which is made of titanium oxide or titanium oxide compound in response to irradiation of ultraviolet ray, and wherein at least one of color tone in the cosmetic preparation is given by an observation color of the observation color changea

Abstract: The invention concerns pearly luster concentrates in the form of an aqueous dispersion having between 10 and 40 wt % pearly luster-forming components and between 15 and 55 wt % emulsifiers. The concentrates contain as emulsifiers alkylpolyglycosides of general formula (I), RO—(Z)x, in which R stands for a C6 to C22 alkyl group, Z stands for a mono or oligosaccharide, x is a number from 1.1 to 5, or their addition products with 1 to 10 molecules ethylene oxide and/or propylene oxide. The concentrates are characterized by a Newtonian flow behaviour when they are free of emulsifiers with —COO—and —OSO3 —groups, such that these concentrates are considerably easier to handle.

Abstract: The present invention relates to stable aqueous formulations of the insect repellent ethyl 3-(N-butyl-acetamino)propionate.

Abstract: Aerosol formulations comprising: (A) A medicament in particulate form and having a surface coating of a surfactant; (B) A hydrogen-containing fluorocarbon or chlorofluorocarbon propellant; and (C) A cosolvent having higher polarity than the propellant which cosolvent is present in an amount of up to 5% w/w based upon propellant; and methods for their preparation.

Abstract: A composition and method of treating cutaneous infection and resulting inflammation in animals known as hot spots and mange, respectively, as well as related veterinarian dermatological conditions. The composition includes L-glutathione and a source of selenium which act synergistically and which are included in a suitable topical carrier for topical application.

Abstract: A microemulsion containing (A) a highly polar and fat-soluble oil drug, a highly polar oil and a lowly polar oil, (B) a polyglycerol mono-fatty acid ester and (C) a water-soluble polyhydric alcohol, wherein the amount of (B) is 0.3 to 3 parts by weight based on one part by weight of (A) and the amount of (C) is 0.1 to 3 parts by weight based on one part by weight of the total amount of (A) and (B). The present invention makes it possible to make a microemulsion containing a highly polar and fat-soluble drug which is highly stable.

Abstract: Methods and apparatus for improving administration of drugs through the use of heat and other physical means. The present invention relates to the use of heat and other physical means in conjunction with specially designed dermal drug delivery systems, conventional commercial dermal drug delivery systems, or drugs delivered into a sub-skin depot site via injection and other methods to alter, mainly increase, the drug release rate from the dermal drug delivery systems or the depot sites to accommodate certain clinical needs.

Abstract: The present invention relates to a novel process for preparing sol-gel microcapsules loaded with up to 95% (w/w) functional molecules or substances and to the products obtained by said process. Said process is conducted in two steps: (a) creating an oil-in-water emulsion by emulsification of a water insoluble solution comprising the sol-gel precursors and the molecules to be loaded, in an aqueous solution under appropriate shear forces; (b) mixing and stirring said emulsion with an aqueous solution at a suitably selected pH to obtain loaded sol-gel microcapsules in suspension. The microcapsules so obtained can further be subjected to cycles of isolation and rinsing. Incorporation of the final product, either in the form of a suspension or a powder, in cosmetic formulations affords a transparent cream when applying to skin and has a smooth and pleasant contact.

Abstract: A water-base agrochemical composition containing a polyether-modified organopolysiloxane compound as a spreader is proposed to improve spreadability of the agricultural chemical compound over plants. The polyether-modified organopolysiloxane compound is characterized by a specific weight fraction of the polyoxyethylene units and a specific molecular weight of the compound so as to exhibit high and stable surface activity in an aqueous solution over a wide range of the pH value.